Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX 317.50
+14.00 (4.61%)
Feb 21, 2025, 5:07 PM BST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 11.44 million as of February 21, 2025. Its market cap has decreased by -71.15% in one year.
Market Cap
11.44M
Enterprise Value
12.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
317.50
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 11.44M, an increase of 7.14%. That is a compound annual growth rate of 0.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| GSK plc | 58.32B |
| Haleon | 35.36B |
| Smith & Nephew | 9.01B |
| Hikma Pharmaceuticals | 5.12B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.17B |